| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.07. | NewGenIVF Group Limited: NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million | 2 | GlobeNewswire (USA) | ||
| 01.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22.06. | NewGenIVF Group Limited: NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization | 217 | GlobeNewswire (Europe) | BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company") today announced that NewGen's total outstanding shares now stand at 10,073,535 following... ► Artikel lesen | |
| 18.06. | NewGenIVF Group Limited: NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested | 459 | GlobeNewswire (Europe) | K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific... ► Artikel lesen | |
| 18.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 16.06. | NewGenIVF Group Limited: NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure | 3 | GlobeNewswire (USA) | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 11.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 04.06. | NewGenIVF Group Limited: NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy | 290 | GlobeNewswire (Europe) | NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 04.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 28.05. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 25.05. | K25.ai Receives $2M Investment From NIVF | 1 | FinSMEs | ||
| 22.05. | Singapore's K25.ai secures $2M strategic investment from NIVF | 1 | TechNode | ||
| 21.05. | NewGenIVF Group Limited: NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation | 2 | GlobeNewswire (USA) | ||
| 21.05. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.05. | NewGenIvf reports FY results | 1 | Seeking Alpha | ||
| 04.05. | NewGenIVF Group Limited: NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress | 746 | GlobeNewswire (Europe) | NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF... ► Artikel lesen | |
| 01.04. | NewGenIVF Group Limited: NewGen Filed 2025 Annual Report on Form 20-F | 1 | GlobeNewswire (USA) | ||
| 31.03. | NewGenIvf Group Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 11.03. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.03. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,260 | +2,84 % | Plus Therapeutics Inc.: Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide CSF Assay Platform | HOUSTON and LAKE FOREST, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company") and Genomic Testing Cooperative, LCA ("GTC") today announced a collaboration... ► Artikel lesen | |
| ORGANON | 11,755 | -0,59 % | Organon & Co. - 8-K, Current Report | ||
| QUIDELORTHO | 14,505 | -0,72 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,115 | +0,45 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| ROCKWELL MEDICAL | 6,295 | 0,00 % | Rockwell Medical regains compliance with Nasdaq minimum bid price requirement | ||
| NUWELLIS, INC | 2,930 | -2,33 % | Nuwellis, Inc.: Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies | MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| NEURONETICS | 1,780 | +0,85 % | Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes | Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson promoted to Executive Vice President and General... ► Artikel lesen | |
| PULSE BIOSCIENCES | 25,200 | +0,80 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| OPTIMIZERX | 6,510 | 0,00 % | OptimizeRx Corporation: OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| PAVMED | 4,870 | -2,21 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 9,850 | 0,00 % | CMS-Kehrtwende bei Kostenerstattung: Canaccord bestätigt "Buy"-Rating für Orthofix Medical | ||
| OWLET | 5,640 | 0,00 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo | ||
| PICARD MEDICAL | 0,123 | 0,00 % | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen | |
| QTREX QUANTUM | 1,185 | -0,42 % | QTREX Quantum Ltd.: QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director |